What Bausch + Lomb does

Bausch + Lomb is a global eye health company founded in 1853 and headquartered in Vaughan, Ontario, Canada. It is publicly traded on the New York Stock Exchange and Toronto Stock Exchange under ticker BLCO following a 2022 spinoff from Bausch Health (formerly Valeant Pharmaceuticals). The company operates through three core business units: Vision Care (contact lenses and lens care solutions), Pharmaceuticals (prescription and over-the-counter eye medications), and Surgical (ophthalmic devices, intraocular lenses, and delivery systems). It serves a dual customer base — eye care professionals (ophthalmologists, optometrists) on the surgical and prescription side, and consumers on the OTC and contact lens side — with a portfolio of more than 400 products distributed in nearly 100 countries and supported by a workforce of more than 12,000.

The product portfolio centers on proprietary contact-lens technologies including MoistureSeal (a two-phase manufacturing process fusing PVP into a silicone hydrogel matrix for high water content and surface wettability), ComfortFeel (moisturizers and osmoprotectants retained over 16 hours), Surface Active Technology (PVP dehydration barrier), and the 3-Zone Progressive Design for multifocal lenses. The company is also developing a bioactive contact lens using polymerized hyaluronic acid (described as the first new contact lens material in over 25 years) and a silicone hydrogel daily lens for myopia progression. On the surgical side, it markets the enVista IOL portfolio (including enVista Envy and enVista Aspire), the Stellaris Elite vision enhancement system, the TENEO excimer laser platform, the ScoutPro tear osmolarity diagnostic (from the Trukera Medical acquisition), and the ELIOS minimally invasive glaucoma surgery system in development. Pharmaceutical brands include XIIDRA and MIEBO for dry eye disease, plus a glaucoma Rx portfolio. Consumer brands include Blink, Artelac, Ocuvite, PreserVision, and the recent Blink Triple Care Preservative Free launch.

Bausch + Lomb generates revenue primarily through hardware sales of prescription pharmaceuticals, contact lenses, lens care solutions, OTC consumer eye health products, and surgical equipment. Its go-to-market combines direct-to-consumer retail through Amazon, CVS, Target, and Walgreens, enterprise field sales to eye care professionals for surgical and Rx products, and channel partnerships such as the Walmart in-store eye care clinics announced in May 2025. Distribution is augmented by proprietary digital infrastructure including the Opal digital marketplace (US, launched October 2024) and BauschOnline for ECPs. Pricing for consumer products varies by retailer; Rx and surgical pricing is not publicly disclosed. The UK subsidiary, Bausch & Lomb U.K. Limited (registered in England and Wales), operates from Kingston upon Thames and London and serves more than 3,500 UK customers with a workforce exceeding 150. Reported annual revenue is approximately $5.1 billion.

Name

Bausch + Lomb

Legal name

Bausch & Lomb U.K. Limited

Website

https://bausch.co.uk

Company type

Public

Founded year

1853

Operating status

Operating

Headcount range

51–100 employees

Short description

Bausch + Lomb is an eye health company founded in 1853 that develops and sells contact lenses, lens care products, pharmaceuticals, and ophthalmic surgical devices across 400+ products in nearly 100 countries, serving eye care professionals and consumers.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113), Ophthalmic Goods Merchant Wholesalers (423460)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)

akta.pro secondary industries

Ophthalmology Specialty Pharmaceuticals (HLAIACAK), Ophthalmology Pharmaceuticals (HLAIAAAL)

Keywords

• Ophthalmic medical devices
• Contact lens products
• Ocular pharmaceuticals
• Ophthalmic surgical equipment
• Lens care solutions

Headquarters

HQ city

Thames Ditton

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel

Revenue model

1. Contact Lenses: Sale of daily disposable, monthly, and specialty contact lenses including ULTRA, Biotrue, PureVision, and SofLens brands.
2. Lens Care Products: Multi-purpose solutions, peroxide systems, and cleaners for soft and rigid gas permeable contact lenses including ReNu and Biotrue brands.
3. Prescription Pharmaceuticals: Prescription eye medications including treatments for glaucoma, dry eye disease, eye allergies, conjunctivitis, anti-infectives, steroids, and diagnostic preparations.
4. Consumer Eye Health OTC: Over-the-counter products including dry eye relief, allergy drops, and eye vitamins (Ocuvite, PreserVision).
5. Surgical Devices and IOLs: Cataract, vitreoretinal, and refractive surgical equipment, intraocular lenses (IOLs), and delivery systems.
6. Dermatology/Aesthetics: Distribution of Solta Medical aesthetic devices for skin tightening, resurfacing, body sculpting and acne treatment.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

Core offering

Bausch + Lomb manufactures and sells ophthalmic products across contact lenses, lens care solutions, prescription and over-the-counter eye health pharmaceuticals, and surgical devices (including intraocular lenses, MIGS systems, vitreoretinal and cataract platforms). It sells these products both directly to consumers through mass retail and online channels and through professional sales channels to ophthalmologists, optometrists, and surgical centers across nearly 100 countries.

Product overview

Bausch + Lomb is a global eye health company with over 170 years of history operating through three core business units: Vision Care, Pharmaceuticals, and Surgical. The Vision Care portfolio includes daily and monthly contact lenses (Biotrue ONEday, Bausch + Lomb ULTRA, ULTRA ONE DAY, PureVision2, SofLens) and lens care solutions (Biotrue Multi-Purpose Solution, ReNu Advanced, ReNu MultiPlus, EasySept). The Pharmaceuticals portfolio spans prescription drugs for glaucoma and dry eye disease (including XIIDRA, MIEBO), over-the-counter consumer eye health products (Blink eye drops, Artelac eye drops, Ocuvite and PreserVision vitamins), and Rx pharmaceuticals (anti-infectives, steroids, mydriatics). The Surgical portfolio includes intraocular lenses (enVista, Luxlife), the ELIOS MIGS system, ScoutPro diagnostic device, Stellaris Elite system, and TENEO laser platform. The company also launched the Opal Digital Marketplace for e-commerce distribution.

Differentiator

Problem solved

Functional benefit

Brands

• Blink: Contact lens rewetting drops and eye drops product line including Blink-N-Clean, Blink Intensive, Blink Contacts, and Blink Refreshing products.
• Ocuvite
• Artelac
• PreserVision
• Vivioptal
• Luxlife
• enVista
• ELIOS
• MIEBO
• XIIDRA
• ScoutPro
• Stellaris Elite
• TENEO
• Opal
• Arise

Products and services

• Bausch + Lomb ULTRA ONE DAY Spherical Daily disposable silicone hydrogel spherical contact lens featuring Advanced MoistureSeal and ComfortFeel technologies, high Dk/t (134), low modulus, UV blocking, and High Definition Optics for clear vision all day; intended for vision correction.
• Bausch + Lomb ULTRA ONE DAY Multifocal Daily disposable multifocal contact lens for presbyopes (eyes over 40) combining 3-Zone Progressive Design with Advanced MoistureSeal and ComfortFeel Technologies for seamless near, intermediate, and distance vision and all-day moisture retention.
• Biotrue ONEday Spherical Daily disposable contact lens with 78% water content inspired by eye biology, Surface Active Technology using PVP and a Poloxamer 407 dehydration barrier, providing up to 16 hours of moisture retention and spherical aberration control.
• Biotrue ONEday for Astigmatism Daily disposable toric contact lens with stable, minimal rotation on eye and High Definition Optics designed to reduce halos and glare in low-light conditions; for patients with astigmatism.
• Biotrue ONEday for Presbyopia Daily disposable multifocal contact lens with 3-Zone Progressive Design providing seamless transitions between near, intermediate, and distance vision.
• Bausch + Lomb ULTRA Spherical Monthly silicone hydrogel contact lens with MoistureSeal Technology maintaining 95% of moisture for 16 hours, High Definition Optics for sharp vision, and extended wear capability up to 7 days.
• Bausch + Lomb ULTRA for Astigmatism Monthly toric contact lens with OpticAlign Design for stable on-eye positioning and High Definition Optics for reduction in halos and glare in low light.
• Bausch + Lomb ULTRA for Presbyopia Monthly multifocal contact lens with seamless transitions between near, intermediate, and distance vision for natural focus shifting.
• Bausch + Lomb ULTRA Multifocal for Astigmatism Monthly multifocal toric contact lens combining 3-Zone Progressive Design with OpticAlign Design for stable, consistently clear vision at all distances with minimal lens rotation.
• Arise Orthokeratology Lens System Cloud-based orthokeratology lens system with FDA-cleared lenses designed for pediatric myopia management in the United States.
• Biotrue Multi-Purpose Solution Soft contact lens multi-purpose solution inspired by eye biology, containing hyaluronan lubricant and balanced pH matching healthy tears; provides up to 20 hours of cushioning and rehydration with a dual disinfectant system.
• ReNu Advanced Multi-Purpose Solution Soft contact lens solution with a triple disinfectant system that kills 99.9% of germs in 4 hours and provides 20 hours of moisture through two surfactants; conditions and hydrates lenses for all-day comfort.
• ReNu MultiPlus Multi-Purpose Solution Soft contact lens solution with DYMED for disinfection, providing cleaning, rinsing, disinfecting, protein removal, and storage up to 30 days.
• ReNu MPS Multi-Purpose Solution Multi-purpose solution specially formulated for sensitive eyes; rinses, lubricates, disinfects, and stores soft contact lenses including silicone hydrogels.
• EasySept Peroxide Solution One-step preservative-free 3% hydrogen peroxide disinfection system for all soft contact lenses including silicone hydrogel; suitable for sensitive eyes.
• Boston Advance Cleaner Tinted daily cleaner used as part of a two-step cleaning process for rigid gas permeable and hard contact lenses to remove stubborn deposits.
• Blink Intensive Triple Action 3 in 1 Eye Drops Combination eye drops with liposomes, sodium hyaluronate, and vitamin E designed to soothe, moisturize, and protect dry-feeling and irritated eyes.
• Blink Intensive Tears Plus Liquid Gel Eye Drops More viscous liquid gel formulation providing lasting relief for persistent dry-feeling eyes; suitable for day-time and night-time use.
• Artelac Every Day Eye Drops Preservative-free eye drops containing a natural moisturizer found in healthy tear film; provides fast-acting and long-lasting relief from dry eye symptoms and can be used with all types of contact lenses during wear.
• Artelac Night Eye Drops Eye drops with an intelligent hydration system supporting all three layers of the tear film; suitable for overnight use to relieve dry, tired, burning, and tearing eyes.
• Artelac Protect Eye Drops Eye drops containing Ectoin (a natural cell-protective molecule) and sodium hyaluronate; reinforce the natural eye barrier against allergens and provide soothing relief.
• Artelac Rebalance Eye Drops Eye drops that remain on the eye surface supplementing the natural tear film for long-lasting hydration; compatible with all soft and rigid contact lenses during wear.
• Artelac Nighttime Eye Gel Highly viscous eye lubricant supporting all three layers of the tear film for long-lasting moistening and protection of the ocular surface; locks in moisture for overnight relief.
• Ocuvite Complete Capsules Premium eye supplement containing DHA omega-3, Zinc, Lutein, Zeaxanthin, and Vitamins C and E; supports normal vision and protects cells from oxidative stress.
• Ocuvite Lutein Capsules Eye supplement containing Lutein, Zinc, Vitamin E, Vitamin C, and Copper; supports maintenance of normal vision and protection from oxidative stress.
• PreserVision Lutein Softgels Eye supplement based on a formulation developed with the U.S. National Eye Institute; contains Lutein and Zinc supporting normal vision.
• Blink Triple Care Preservative Free Eye Drops Preservative-free lubricant eye drops with a lipid-based formula enhanced with hyaluronate providing instant, long-lasting dry eye symptom relief for up to 10 hours with dual-action moisture seal.
• Prescription Glaucoma Pharmaceuticals Prescription pharmaceutical products for glaucoma treatment including eye drops to lower eye pressure, laser therapy support products, and surgical interventions for fluid drainage enhancement.
• XIIDRA (lifitegrast) Prescription eye drop for the treatment of dry eye disease; acquired from Novartis for approximately $2.5 billion.
• MIEBO Prescription eye drop for the treatment of dry eye disease; featured among Bausch + Lomb scientific presentations at ASCRS 2026.
• Ophthalmic Surgical Product Portfolio Range of equipment, devices, and instrumentation for cataract, corneal refractive, glaucoma, and retinal procedures, including intraocular lenses (IOLs), phacoemulsification and vitreoretinal systems, and surgical delivery systems.
• enVista Envy Intraocular Lens FDA-approved intraocular lens for cataract surgery, part of the enVista IOL portfolio including enVista Aspire.
• Luxlife Intraocular Lens Intraocular lens that received CE mark certification for manufacture in Europe; features a different optical design platform with excellent visual outcomes in clinical trials, available in non-toric and toric versions.
• Stellaris Elite Vision Enhancement System Surgical vision enhancement system for cataract and vitreoretinal procedures, part of Bausch + Lomb's surgical product portfolio.
• TENEO Excimer Laser Platform Excimer laser platform for refractive surgery procedures, part of Bausch + Lomb's surgical portfolio presented at ASCRS 2026.
• ScoutPro Osmolarity Testing Device Portable tear osmolarity measuring platform acquired from Trukera Medical; integrated into Bausch + Lomb's U.S. surgical and dry eye disease operations for corneal surface disease diagnostics.
• ELIOS MIGS System Minimally invasive glaucoma surgery system currently in development and not yet available for sale in the United States; part of Bausch + Lomb's surgical portfolio presented at ASCRS 2026.
• Opal Digital Marketplace Digital marketplace platform launched in the United States to support online distribution of eye care products.

Quantifiable outcome

• 96% moisture retention for 16 hours with ULTRA ONE DAY
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Four partnerships are on record, tiered core and minor.

• WalmartcoreChannel Partner/ Reseller/ Distributor · 9 May 2025Partnership for in-store eye care clinics expanding retail distribution presence for eye care products and services in Walmart stores across the United States.
• Whitecap BiosciencesminorStrategic or Co-development Partner · 1 January 2025Acquisition to bolster pipeline with additional eye health technologies and potential therapeutics development.
• Trukera MedicalcoreTechnology or Integration · 1 July 2024Acquisition of Trukera Medical, a US-based company specializing in tear osmolarity testing and corneal surface disease diagnostics, integrating ScoutPro portable tear osmolarity measuring platform into surgical and dry eye operations.
• CPI (Centre for Process Innovation)minorStrategic or Co-development PartnerPartnership for AI-powered drug discovery focused on eye disease treatments, leveraging CPI's process innovation capabilities for development of novel ophthalmic therapeutics.

Scale indicators6 records

Recent moves8 records

Expansion highlights7 records

Direct peers

• CooperVision: CooperVision is a direct peer in contact lenses, particularly active in silicone hydrogel, toric, multifocal, and specialty lenses including orthokeratology (Paragon Vision Sciences). It also acquired SynergEyes, expanding its specialty lens portfolio competing with B+L.
• Alcon: Alcon is the closest direct peer to Bausch + Lomb, operating in contact lenses, ophthalmic surgical devices, and dry eye/eye pharmaceuticals. Both companies sell IOLs, phaco/vitreoretinal equipment, lens care, and prescription eye drops to overlapping ophthalmologist and optometrist customers globally.
• HOYA Corporation: HOYA is a direct peer in intraocular lenses through its HOYA Surgical Optics division and offers photochromic and eyeglass lens products. Its IOL portfolio competes with B+L's enVista and Luxlife in cataract surgery channels.
• Carl Zeiss Meditec: Carl Zeiss Meditec is a direct peer in ophthalmic surgical devices, including IOLs, surgical microscopes, and refractive laser platforms. Its cataract and refractive surgery portfolio competes directly with B+L's enVista, Luxlife, Stellaris Elite, and TENEO systems.
• Johnson & Johnson Vision (Acuvue): J&J Vision competes head-to-head with B+L in the global contact lens category through the Acuvue franchise, including daily disposable, multifocal, and toric lenses. Overlapping retailer distribution and consumer segments make it a primary direct competitor in vision care.

Emerging players

• STAAR Surgical: STAAR Surgical specializes in implantable collamer lenses (ICL/EVO Visian) for refractive vision correction, competing with B+L's IOL and refractive surgery portfolios (TENEO excimer laser) in the premium refractive surgery segment.
• Glaukos Corporation: Glaukos is a focused MIGS (minimally invasive glaucoma surgery) company whose iStent platform directly competes with B+L's in-development ELIOS MIGS system. It is a direct emerging competitor in the surgical glaucoma segment.
• Ocular Therapeutix: Ocular Therapeutix is an emerging ophthalmic specialty pharmaceutical company developing sustained-release therapies for glaucoma, dry eye, and other ocular conditions, partially overlapping with B+L's prescription pharmaceutical franchise.

Broad incumbents

• EssilorLuxottica: EssilorLuxottica is a broad incumbent in optical goods, controlling lens and frame brands (Varilux, Crizal, Ray-Ban, Oakley) and a global retail network (LensCrafters, Sunglass Hut). It is complementary rather than fully overlapping, since B+L is not in frames, but it is a strategic anchor in adjacent eye-care value chains.

Regional players

• Sun Pharma (Tarsier Pharma / ophthalmic division): Sun Pharma operates a significant ophthalmic specialty business, particularly in India and emerging markets, with branded generics and specialty eye care products. It is a regional and adjacent player rather than a direct global competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/bauschlombuk
• Facebookfacebook.com/BauschandLombUK
• LinkedInlinkedin.com/company/bausch-lomb-uk

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bausch + Lomb